| Literature DB >> 35270808 |
Arianna Scala1, Teresa Angela Trunfio2, Lucia De Coppi1, Giovanni Rossi3, Anna Borrelli3, Maria Triassi1,4, Giovanni Improta1,4.
Abstract
Background: Valvular heart diseases are diseases that affect the valves by altering the normal circulation of blood within the heart. In recent years, the use of valvuloplasty has become recurrent due to the increase in calcific valve disease, which usually occurs in the elderly, and mitral valve regurgitation. For this reason, it is critical to be able to best manage the patient undergoing this surgery. To accomplish this, the length of stay (LOS) is used as a quality indicator.Entities:
Keywords: length of stay; regression; valvuloplasty
Mesh:
Year: 2022 PMID: 35270808 PMCID: PMC8910439 DOI: 10.3390/ijerph19053117
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Features of dataset.
| Features | Dataset |
|---|---|
| Gender | |
| M | 199 |
| F | 180 |
| AMI | |
| Yes | 13 |
| No | 366 |
| CHF | |
| Yes | 118 |
| No | 261 |
| CeVD | |
| Yes | 16 |
| No | 363 |
| PVD | |
| Yes | 11 |
| No | 368 |
| COPD | |
| Yes | 27 |
| No | 352 |
| Diabetes | |
| Yes | 17 |
| No | 362 |
| RD | |
| Yes | 27 |
| No | 352 |
| 2 Procedures | |
| Yes | 135 |
| No | 244 |
| 3 Procedures | |
| Yes | 33 |
| No | 347 |
| 4 Procedures | |
| Yes | 11 |
| No | 370 |
Figure 1Partial regression plot (pre-operative LOS).
Pearson correlation and statistical significance.
| Pearson Correlation | Variable/Variable | LOS | Age | Gender | Pre-operative LOS | AMI | CHF | PVD | CeVD | COPD | Diabetes | RD | 2 procedures | 3 procedures | 4 procedures |
| LOS | 1.000 | 0.098 | −0.031 | 0.829 | −0.010 | 0.231 | 0.184 | 0.081 | 0.005 | 0.035 | 0.047 | 0.105 | 0.106 | 0.098 | |
| Age | 0.098 | 1.000 | 0.126 | −0.034 | −0.033 | 0.117 | 0.069 | 0.084 | 0.111 | 0.145 | 0.195 | 0.106 | 0.081 | 0.025 | |
| Gender | −0.031 | 0.126 | 1.000 | −0.048 | −0.063 | −0.035 | −0.070 | 0.011 | −0.140 | −0.053 | −0.079 | −0.001 | −0.013 | −0.058 | |
| Pre-operative LOS | 0.829 | −0.034 | −0.048 | 1.000 | 0.026 | 0.143 | 0.117 | 0.064 | −0.002 | 0.043 | 0.005 | 0.081 | 0.048 | 0.084 | |
| AMI | −0.010 | −0.033 | −0.063 | 0.026 | 1.000 | −0.001 | −0.033 | 0.033 | 0.004 | 0.029 | 0.061 | −0.110 | −0.007 | −0.031 | |
| CHF | 0.231 | 0.117 | −0.035 | 0.143 | −0.001 | 1.000 | 0.053 | −0.056 | 0.057 | 0.019 | 0.035 | 0.154 | 0.055 | 0.103 | |
| PVD | 0.184 | 0.069 | −0.070 | 0.117 | −0.033 | 0.053 | 1.000 | 0.042 | −0.048 | −0.037 | 0.074 | 0.101 | 0.170 | −0.028 | |
| CeVD | 0.081 | 0.084 | 0.011 | 0.064 | 0.033 | −0.056 | 0.042 | 1.000 | −0.058 | 0.145 | 0.095 | −0.047 | 0.028 | −0.035 | |
| COPD | 0.005 | 0.111 | −0.140 | −0.002 | 0.004 | 0.057 | −0.048 | −0.058 | 1.000 | −0.010 | 0.003 | −0.013 | 0.096 | 0.018 | |
| Diabetes | 0.035 | 0.145 | −0.053 | 0.043 | 0.029 | 0.019 | −0.037 | 0.145 | −0.010 | 1.000 | 0.039 | 0.052 | 0.069 | 0.203 | |
| RD | 0.047 | 0.195 | −0.079 | 0.005 | 0.061 | 0.035 | 0.074 | 0.095 | 0.003 | 0.039 | 1.000 | −0.013 | 0.024 | −0.046 | |
| 2 procedures | 0.105 | 0.106 | −0.001 | 0.081 | −0.110 | 0.154 | 0.101 | −0.047 | −0.013 | 0.052 | −0.013 | 1.000 | 0.415 | 0.221 | |
| 3 procedures | 0.106 | 0.081 | −0.013 | 0.048 | −0.007 | 0.055 | 0.170 | 0.028 | 0.096 | 0.069 | 0.024 | 0.415 | 1.000 | 0.533 | |
| 4 procedures | 0.098 | 0.025 | −0.058 | 0.084 | −0.031 | 0.0103 | −0.028 | −0.035 | 0.018 | 0.203 | −0.046 | 0.221 | 0.533 | 1.000 | |
| Sign. | Variable/Variable | LOS | Age | Gender | Pre-operative LOS | AMI | CHF | PVD | CeVD | COPD | Diabetes | RD | 2 procedures | 3 procedures | 4 procedures |
| LOS | . | 0.028 | 0.275 | 0.000 | 0.425 | 0.000 | 0.000 | 0.058 | 0.463 | 0.250 | 0.183 | 0.020 | 0.020 | 0.028 | |
| Age | 0.028 | . | 0.007 | 0.252 | 0.263 | 0.011 | 0.090 | 0.051 | 0.015 | 0.002 | 0.000 | 0.020 | 0.058 | 0.316 | |
| Gender | 0.275 | 0.007 | . | 0.177 | 0.110 | 0.250 | 0.087 | 0.419 | 0.003 | 0.152 | 0.063 | 0.490 | 0.403 | 0.131 | |
| Pre-operative LOS | 0.000 | 0.252 | 0.177 | . | 0.304 | 0.003 | 0.011 | 0.105 | 0.482 | 0.202 | 0.459 | 0.058 | 0.177 | 0.052 | |
| AMI | 0.425 | 0.263 | 0.110 | 0.304 | . | 0.488 | 0.264 | 0.264 | 0.468 | 0.285 | 0.120 | 0.016 | 0.448 | 0.274 | |
| CHF | 0.000 | 0.011 | 0.250 | 0.003 | 0.488 | . | 0.150 | 0.138 | 0.132 | 0.353 | 0.247 | 0.001 | 0.142 | 0.023 | |
| PVD | 0.000 | 0.090 | 0.087 | 0.011 | 0.264 | 0.150 | . | 0.208 | 0.176 | 0.234 | 0.074 | 0.025 | 0.000 | 0.290 | |
| CeVD | 0.058 | 0.051 | 0.419 | 0.105 | 0.264 | 0.138 | 0.208 | . | 0.129 | 0.002 | 0.032 | 0.183 | 0.292 | 0.251 | |
| COPD | 0.463 | 0.015 | 0.003 | 0.482 | 0.468 | 0.132 | 0.176 | 0.129 | . | 0.420 | 0.476 | 0.399 | 0.030 | 0.360 | |
| Diabetes | 0.250 | 0.002 | 0.152 | 0.202 | 0.285 | 0.353 | 0.234 | 0.002 | 0.420 | . | 0.224 | 0.157 | 0.091 | 0.000 | |
| RD | 0.183 | 0.000 | 0.063 | 0.459 | 0.120 | 0.247 | 0.074 | 0.032 | 0.476 | 0.224 | . | 0.399 | 0.323 | 0.188 | |
| 2 procedures | 0.020 | 0.020 | 0.490 | 0.058 | 0.016 | 0.001 | 0.025 | 0.183 | 0.399 | 0.157 | 0.399 | . | 0.000 | 0.000 | |
| 3 procedures | 0.020 | 0.058 | 0.403 | 0.177 | 0.448 | 0.142 | 0.000 | 0.292 | 0.030 | 0.091 | 0.323 | 0.000 | . | 0.000 | |
| 4 procedures | 0.028 | 0.316 | 0.131 | 0.052 | 0.274 | 0.023 | 0.290 | 0.251 | 0.360 | 0.000 | 0.188 | 0.000 | 0.000 | . |
Collinearity statistics.
| Independent Variables | Tolerance | Variance Inflation Factor |
|---|---|---|
| Age | 0.871 | 1.148 |
| Gender | 0.926 | 1.080 |
| Pre-operative LOS | 0.947 | 1.056 |
| AMI | 0.973 | 1.028 |
| CHF | 0.931 | 1.074 |
| PVD | 0.913 | 1.095 |
| CeVD | 0.943 | 1.060 |
| COPD | 0.932 | 1.073 |
| Diabetes | 0.907 | 1.102 |
| RD | 0.933 | 1.072 |
| 2 Procedures | 0.783 | 1.277 |
| 3 Procedures | 0.576 | 1.736 |
| 4 Procedures | 0.652 | 1.534 |
Figure 2Homoscedasticity of the data.
Figure 3P–P plot.
Figure 4Cook’s distance.
Model summary.
| R | R2 | R2 Adjusted | Std. Error of the Estimate | |
|---|---|---|---|---|
| MLR Model | 0.850 | 0.722 | 0.712 | 6.331 |
Standardized and Unstandardized coefficients with the p-values of the MLR analysis.
| Variable | Unstandardized Coefficients | Standardized | t | ||
|---|---|---|---|---|---|
| Coefficient | Std. Error | ||||
| Intercept | 3.441 | 2.003 | 1.718 | 0.087 | |
| Age | 0.106 | 0.029 | 0.107 | 3.623 |
|
| Gender | −0.018 | 0.677 | −0.001 | −0.027 | 0.978 |
| Pre-operative LOS | 1.009 | 0.035 | 0.809 | 28.558 |
|
| AMI | −1.773 | 1.812 | −0.027 | −0.979 | 0.328 |
| CHF | 2.548 | 0.728 | 0.100 | 3.502 |
|
| PVD | 4.586 | 2.027 | 0.065 | 2.262 |
|
| CeVD | 1.349 | 1.665 | 0.023 | 0.810 | 0.418 |
| COPD | −0.536 | 1.310 | −0.012 | −0.410 | 0.682 |
| Diabetes | −1.210 | 1.649 | −0.021 | −0.734 | 0.464 |
| RD | 0.552 | 1.309 | 0.012 | 0.422 | 0.673 |
| 2 Procedures | −0.358 | 0.767 | −0.015 | −0.466 | 0.642 |
| 3 Procedures | 2.002 | 1.520 | 0.048 | 1.317 | 0.189 |
| 4 Procedures | 0.166 | 2.513 | 0.002 | 0.066 | 0.947 |
Evaluation metrics for the regression analysis.
| RF | NNN | Linear SVM | Rational Quadratic GPR | |
|---|---|---|---|---|
| R2 | 0.670 | 0.580 | 0.690 | 0.710 |
| Root Mean Squared Error | 6.819 | 7.648 | 6.545 | 6.390 |
Figure 5Random forest.
Figure 6Narrow neural network.
Figure 7Linear support vector machine.
Figure 8Rational quadratic GPR.